Photo Gallery

Kifah Precast Company (KPC) is a leading provider of precast solutions in the Kingdom of Saudi Arabia. With a commitment to excellence, KPC delivers high-quality products tailored to meet the needs of diverse construction projects, from residential to commercial developments. Our state-of-the-art facilities, advanced technologies, and skilled workforce enable us to offer innovative and sustainable solutions to our clients. From design to production, KPC maintains rigorous quality standards to ensure the durability and integrity of our products. With a focus on customer satisfaction and continuous improvement, KPC strives to be a trusted partner in the construction industry, delivering projects on time and within budget. In addition to precast solutions, Kifah Precast Company specializes in the Al Kifah Modular System, offering rapid and versatile building solutions which is rapid construction of modular buildings, providing flexibility, cost-effectiveness, and sustainability.

Dr. Firas Khaliel

Head of Cardiac Center, King Faisal Specialist Hospital & Research Center, Riyadh , Saudi Arabia

Dr. Khaliel is the Head of Cardiac Surgery, director of Robotics and MIS Program, lead surgeon VAD/ Transplant Surgeon and Associate Professor of Surgery, Alfaisal University King Faisal Specialist Hospital and Research Centre- Riyadh, Saudi Arabia. Dr Khaliel has a special interest in Heart Failure Management including Heart Transplantation, VADS and PTEs, as well as Redo heart valve surgery, minimal invasive valve surgery and TVI procedures. He is also interested in Robotic multiple valve surgeries with ultrafast track extubation, including Aortic root and complex cardiac surgery. His robotic program excelled to be the only intra- cardiac surgical program in the Middle East and top 5 highest volume with top 3 program in robotic multivalve complex surgery, worldwide. As a great believer in academic teaching and clinical research, Dr Khaliel has been invited to speak at over 200 medical congresses and has authored over 30 papers.

Dr. Vipul Patel

Founder & Executive Director, American Society of Robotic Surgery

Professor of Urology and Director of Global Robotics Institute, Florida, USA

Dr. Patel is the Founder of the pioneering American Society of Robotic Surgery and world’s most experienced robotic surgeon with over 17,000 cases performed. Yearly, Dr. Patel trains hundreds of surgeons on how to safely adopt robotic technology into their surgical practices and leads the robotic training team at the Nicholson Center for Surgical Advancement. Dr. Patel attended medical school at Baylor College of Medicine and did both his residency and fellowship training at the University of Miami. Prior to moving to Florida, he was Director of Robotic and Minimally Invasive Urologic Surgery at The Ohio State University.

Dr. Adnan H. Siddiqui

Professor of Neurosurgery, SUNY University, Buffallo, USA

Dr. Siddiqui is a renowned neurosurgeon and the CEO of the Jacobs Institute (focused on developing novel medical technology) and the Director of the Canon Stroke and Vascular Research Center. He is an influential futurist and renowned academic, having authored over 450 peer reviewed publications. Dr. Siddiqui completed fellowship training in Interventional Neuroradiology, Cerebrovascular Surgery and Neurocritical Care from Thomas Jefferson University in Philadelphia. He completed his Neurosurgical residency at Upstate Medical University and received his PhD in Neuroscience from the University of Rochester and medical degree from Aga Khan University in Pakistan.

Dr. Jacques Marescaux

Founder, Institute of Image-Guided Surgery (IHU Strasbourg)
Founder, IRCAD, Strasbourg, France

Jacques Marescaux is Professor of Surgery, Founder and Member of the Board of the Institute of Image-Guided Surgery (IHU Strasbourg) and President and Founder of IRCAD (1994) a uniquely structured institute advancing the field of surgery into the information era. In addition, he founded the European Institute for Telesurgery (EITS) as a training facility to disseminate the groundbreaking work at IRCAD. Over the last 27 years this center has gained international acclaim by training more than 45,000 surgeons from 124 countries, with 5 additional mirror IRCAD institutes created around the world in Taiwan (2008) and Brazil (Sao Paulo 2011, Rio de Janeiro 2017), Beirut (Lebanon 2019), Kigali (Rwanda 2023). Two additional IRCAD Institutes will be created in 2024, one in Wuxi, near Shanghai, China and the second in the United States in Charlotte.

Dr. Christopher Thompson

Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Dr. Thompson is a Professor of Medicine at Harvard Medical School (HMS), Director of Endoscopy and Co-Director of the Center for Weight Management and Wellness and Brigham and Women’s Hospital (BWH), is Principal Investigator of the Developmental Endoscopy Lab and serves on the HMS admissions committee. He operates on the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE), and is Editor-in-Chief for iGIE, the society’s new open access journal.

Mr. Kurt Azarbarzin

Chief Executive Officer, EndoQuest Robotics, Houston, USA

Kurt Azarbarzin is a 39-year medtech industry veteran, having led the development of over 90 new products representing over $910 million of annual sales at companies including U.S. Surgical, Tyco Healthcare (now Medtronic), Spine Wave, Respimetrix, SurgiQuest, Verb Surgical, and J&J. He has experience in the surgical, robotic, cardiovascular, interventional, orthopedic and urological markets. Kurt founded SurgiQuest in 2005 and sold it to CONMED, whose lead technology AirSeal became the standard of care for advanced laparoscopic and robotic surgery. He then became CEO of Verb Surgical (a joint venture between Google and J&J) consisting of over 550 employees, that was acquired by J&J in January 2020. After that, Kurt became and is currently the CEO of EndoQuest Robotics, which is developing the first endoluminal robotic surgical platform in the world, designed to enable scar-free surgery through the body’s natural orifices.

Dr Santiago Horgan

Chief Division of Minimally Invasive Surgery
Director Center for the Future of Surgery, University di California San Diego, USA

Dr. Horgan, is an internationally recognized expert in esophageal disease, weight-loss surgery, minimally invasive surgery and new technologies and approaches for surgery. He performs a variety of weight-loss procedures including gastric sleeve, gastric plication, gastric bypass, and revisional weight-loss surgeries. He is skilled in the use of surgical robotics and is also a pioneer in the field of natural orifice translumenal endoscopic surgery (NOTES), in which surgical instruments are passed through a natural orifice such as the mouth to reach the desired organ. As the director of the Center for the Future of Surgery at UC San Diego School of Medicine, Dr. Horgan is working with colleagues to investigate, develop, test and teach procedures that are revolutionizing the field of surgery. Dr. Horgan trains surgeons during their fellowship as well as established surgeons from medical centers across the country on minimally invasive surgical techniques.

Dr. Todd Wilson

Chief Medical Officer, EndoQuest Robotics, Houston, USA

Dr. Wilson is an Associate Professor at the University of Texas in Houston where he focuses on the practice, training and innovation of robotic, laparoscopic and endoscopic procedures and surgeries. He has numerous publications and participated in many FDA IDE trials and is the Chief Medical Officer at EndoQuest Robotics. Dr. Todd graduated from the United States Naval Academy and then served as a Surface Warfare Officer in the Navy for six years. He left the Navy as one of the highest decorated officers in his year group to pursue a career in medicine. He attended medical school at The University of Texas Medical School at Houston (now McGovern Medical School) and then continued at the same school for both his residency in General Surgery and then fellowship in Minimally Invasive Surgery.

Dr. Nadine Hachach-Haram

FRCS (Plast), BEM, Founder and CEO, Proximie, London, UK

Dr. Hachach-Haram is the Chief Executive Officer and Founder of Proximie, Consultant Plastic Surgeon and Director of Clinical Innovation & Strategic Partnerships at Guy’s + St Thomas’ NHS Foundation Trust in London, UK. Growing up in post-war Lebanon was a formative experience, shaping her future career not just as a surgeon, but as an entrepreneur. Her initial motivation to help people grew into a wider goal to help bring safe surgery to the world. She created Proximie – a software platform that captures data and generates new insights to improve patient outcomes and OR productivity. Dr. Hachach- Haram is the recipient of the British Empire Medal in the 2018 Queen’s Birthday Honours, and has been selected as an NHS Clinical Entrepreneur, and an Endeavor Entrepreneur. She is also a member of the Royal College of Surgeons’ Commission on the Future of Surgery, consisting of some of the UK’s leading doctors, engineers, data experts, managers, and patient representatives, with the objective to investigate the advances that will transform surgery over the next 20 years, and is faculty at Singularity, and Exponential Medicine.

Dr Ricardo Estape

Director, HCA Florida Institute for Gynecologic Oncology, Miami, USA

Dr. Estape has practiced in the South Florida area for over 20 years and was past director of the gynecologic oncology site group at the University of Miami Sylvester Cancer Center. Dr. Estape is also the Founder and past director of the Division of Gynecologic Oncology at the Miami Cancer Institute and has started and headed up multiple robotic programs at South Miami Hospital, Baptist Health South Florida, Larkin Hospital and now in the HCA system throughout South Florida. He is a pioneer in robotic surgery practicing since 2004 and has performed more robotic gynecologic procedures than any other surgeon in the world, standing at currently over 8000 cases as primary surgeon and many more as the teaching surgeon. Dr. Estape has worked with multiple companies to develop robotic platforms including multi-port robotics, single site robotics, endoluminal robotics and now transvaginal robotics as well, he continues to be a Pioneer in novel robotics and minimally invasive surgery.

Dr. Amit Vohra

(PhD, MBA) Founder, Promaxo and neuro42, San Francisco, USA

Dr. Vohra is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Dr. Amit is Founder and CEO of Promaxo, a medical technology company that develops and commercializes customer-centric MRI and robotic technologies. He is also the Founder and CEO of neuro42, and an Advisory Board Member at the University of Florida’s College of Engineering. Dr. Vohra also serves as a founding board member at 8chili and Navaux, and an advisor to Fanisko, Kyto and AutoSurg.

Dr. Mudhar Hassan

Robotic Surgeon, Mediclinic, Dubai

Dr. Hassan is an expert endourologist and robotic surgeon, with over 16 years experience, concentrating on prostate cancer, renal tumors, upper urinary tract tumors, reconstructive urology and, renal stones. Dr. Hassan has worked at Karolinska University Hospital, Danderyd University Hospital and Karolinska Institute, Stockholm, Sweden. He graduated from the College of Medicine at Baghdad University and completed his urological training at Karolinska University Hospital. Dr. Hassan was the Head of the Department of Urology at Danderyd Hospital and Karolinska Institute between 2012 and 2017.

Dr. Hany Atalah

Head of Robotic Surgery, Hamad Medical Corporation, Doha, Qatar

Dr. Atalah is currently the director of Robotic Surgery at Hamad Medical Corporation, in Doha, Qatar where he oversees the launching and training of junior and senior faculties. There are currently 6 robotics platforms, of which 5 are for clinical use and one for training. Dr. Atalah started his Robotic experience in 2005 in Baltimore, then in 2008 he moved to the University of Florida where he was a Director for Robotic and Minimally Invasive Surgery. In 2011 Dr Atalah moved to Macon Georgia where he served as the Director of Robotic Surgery at HCA hospital. In 2016 Dr. Atalah Joined Mercer Medical School as Professor of Robotic Surgery. He has authored many publications and wrote contributed chapters in academic manuals focused on Robotic Surgery.

Dr. Rabii Madi

Robotic Surgeon, Clemenceau Hospital, Dubai

Dr. Madi is a Urologic Oncologist with 15 years of academic and clinical experience in Urologic Oncology and Minimally Invasive Surgery. He is currently serving as the Director of Urology and Robotic Surgery at Clemenceau Medical Center-Dubai. In the USA, he was the director of robotic surgery at Case Western Reserve in Cleveland before moving to Georgia and heading the Urologic Oncology and Robotic Surgery programs at Augusta University Health for 9 years. Dr. Madi is among the most experienced robotic surgeons in the USA. He has performed more than 2,200 robotic surgeries and has more than 50 peer- reviewed publications and 120 presentations in national and international meetings. He has pioneered new techniques and approaches in urologic oncology and robotic surgery.

Dr. Abdullah Al Ansari

Deputy Chief Medical, Officer, Hamad Medical Corporation, Qatar

Dr. Al Ansari is currently the Chief Medical Officer and Chairman of surgery at Hamad Medical Corporation (HMC), Associate Dean for Clinical Medicine and Weill Cornell Medical School-Qatar. He is the pioneer of robotic surgery in Qatar. He graduated from the Royal College of Surgeons in Ireland (RCSI) and is a fellow of both RCSI and Edinburgh and completed the New and Emerging Academic leadership course (NEAL) in Toronto. Dr. Al Ansari is very passionate about health service in Qatar, and has an ambition for HMC in Qatar to be the best health system internationally. He continues his research in the form of publications and conducting animal labs and workshops and conferences. His special interests include teaching younger surgeons and mentoring them in their training.

Amit Hazan

Robotic Surgery Analyst, New York, USA

Amit Hazan is a former Wall Street equity research analyst covering the medical technology sector for nearly 23 years. Mr. Hazan was most recently a Managing Director at Goldman Sachs, where he was head of the medical technology equity research team. Prior to Goldman, Mr. Hazan held similar roles at Citigroup, Oppenheimer (fka CIBC World Markets), SunTrust, and Gleacher & Co. Mr. Hazan holds an undergraduate degree from UCLA and a JD/MBA from Santa Clara University.

Hisham Nada

Ph.D., P.E., Eng., Senior Director, Bridges-Global, Khatib & Alami

Dr. Nada has 35 years of experience in the fields of consultancy and research in Structural Engineering. He has diverse experience in reinforced concrete and steel structures designs dealing with different clients in different countries. He holds a Ph.D. from the University of Nevada, USA with emphasis in bridges design and earthquake engineering and a professional engineer (P.E.) license from the states of California and Texas.

Dr. Jonathan Lee Conroy

Consultant Orthopaedic Surgeon, Healthpoint, Mubadala Healthcare, Abu Dhabi

Jon Conroy is an established Orthopaedic Surgeon from the UK. He has vast experience of treating complex Hip and Knee conditions. He was recruited to Healthpoint Hospital to introduce Mako Robotic Hip and Knee surgery to the region. His experience in Robotic Assisted surgery stretches back 10 years. The first surgeon in England North of London to have a Mako robot he has personally performed around 1,000 robotic cases (the 3rd highest number of surgeries in the UK) before moving to Abu Dhabi in 2022. Jon has performed the first Mako robotic assisted Uni-Compartment Knee Replacement and Total Hip Replacement in the Middle East and the first Mako robotic Total Knee Replacement in the United Arab Emirates. Since 2017 he has certified many senior surgeons across the Middle East, Asia and Europe in his role as a Mako instructor. He continues to be actively involved in teaching robotics. He takes international referrals from across the globe.

Dr. Sean Lavin

Founder and CEO, Alpha Lavin Advisors, Miami, USA

Dr. Lavin is the founder of Alpha Lavin Advisors, a firm focused on helping medical technology, diagnostic, and digital health companies access capital in a cost effective and time sensitive manner. The firm also provides M&A or other strategic advice. Previously, Dr. Lavin began his career as an equity research analyst at Oppenheimer and Co in 2006, then transitioned to Lazard Capital Markets, before helping build the healthcare group at BTIG. Over the past 16 years, Sean has supplied some of the most sought after research ideas and advice on medical devices and diagnostics to approximately 1000 institutional investment funds. He covered approximately fifty public companies while at his previous firms and helped BTIG be involved in raising ~$25B in new capital for healthcare companies from 2013 to 2019. Sean is a physician by training. He graduated from the Massachusetts Institute of Technology (MIT) and then earned his M.D. from the Ohio State University College of Medicine after which, Dr. Lavin was a surgical resident in Miami, FL rotating through all areas of surgery, the ICU, and ER.

Mr. Hamid Jafar

Chairman, Crescent Group, Sharjah

Mr. Hamid Dhiya Jafar is Chairman of the Board of the Crescent Group of Companies, headquartered in Sharjah, United Arab Emirates. Aside from his core business in oil and gas, Mr. Jafar has a variety of other regional and international commercial interests including container shipping terminal operations, transport and logistics, private equity, power generation, and real estate. Hamid Jafar is also Chairman of Gulftainer Ltd. He is also founder of the UAE Chapters of the Young Presidents Organization and the World Presidents Organization, and a member of the international Chief Executives Organization. Separately, Mr. Jafar has promoted and supported important initiatives in higher education at Cambridge University and in the Gulf, and serves as a member of the Board of Trustees and Chairman of the Finance Committee of the American University of Sharjah (AUS). He is also an active supporter of many charities, particularly those in aid of handicapped and needy children, and cancer. Mr. Jafar obtained his BA in Engineering as well as post- graduate studies in Thermodynamics and Fluid Flow at Cambridge University, followed by his MA.

H.E. Helal Saeed Al Marri

Director General Dubai Department of Economy & Tourism, Dubai

His Excellency Helal Saeed Almarri is the Director General of the Dubai Department of Economy and Tourism. He is a member of the Executive Council of Dubai, a member of the Board of Directors of the Investment Corporation of Dubai and also the Director General of the Dubai World Trade Centre Authority (DWTCA). Almarri was recently appointed as chairman of Dubai Financial Market and also serves as a member of the Supreme Committee of the Expo 2020 and board member at the Dubai Chamber of Commerce and Industry, Emaar Properties PJSC and Taaleem PJSC. Almarri’s responsibilities span enhancing Dubai’s positioning as the preferred destination for investment, business and leisure and for developing and strengthening the Emirate’s economy.

H.E. Mansoor Ibrahim Al Mansoori

Chairman, Department of Health, Abu Dhabi

H.E. Mansoor Al Mansoori is a member of Abu Dhabi Executive Council and the Chairman of the Department of Health in Abu Dhabi. HE Mansoor is a prominent leader with a diverse range of professional experiences in senior leadership positions across government and private sector including telecommunications, energy, and technology with a proven track record of setting up strategies, building institutional structures and capabilities, and implementing performance-based management systems. As the Group Chief Operating Officer of G42, HE Mansoor was responsible for Group and operating businesses’ strategic partnerships, innovation, capacity building, business efficiencies and transformation, revenue optimization, brand development, organizational culture and the development of future leaders of G42.

H.E. AbdulRahman Bin Mohamed Al Owais

UAE Minister of Health and Prevention
Cabinet Member and Minister of Health and Prevention,
Minister of State for Federal National Council Affairs

His Excellency Abdul Rahman Al Owais has joined the federal Government in 2006 as Minister of Culture, Youth and Community Development. In addition, he has held the position of Acting Minister of Health from 2011 until 2013 when he was appointed as Minister of Health. In February 2016, the name of the Ministry of Health was changed to Ministry of Health and Prevention, increasing the responsibilities of the ministry to focus on prevention and protection of society from diseases in addition to regulating the health sector. He has been also appointed as Minister of State for Federal National Council Affairs following the Cabinet reshuffle of October 2017.

Dr. Arif Al Nooryani

CEO, Al Qassimi Hospital, Sharjah

Dr. Arif Al Nooryani is the CEO of Al Qassimi Hospital in Sharjah, United Arab Emirates and a cardiac surgeon. He has implemented several innovative initiatives to improve patient care and safety, including the use of technology and advanced medical equipment. He holds a medical degree from the College of Medicine and Medical Sciences in Germany, a PhD in cardiovascular medicine from the University of Belgrade and is certified by the German Boards of Internal Medicine and Cardiology. Dr.Arif is fluent in Arabic, English, German and Urdu..

Mr. Evans Haji-Touma

Managing Director, Jefferies International, London, UK

Evans has over 25 years+ of investment banking spanning across the EMEA and Asia, Evans is a trusted advisor to some of the world’s largest Sovereign Wealth Funds and Pension Funds, Family Groups, Sponsors, Infrastructure Funds and other Private Capital Providers. Evans Joined Jefferies in February 2022 and is responsible for Jefferies’ equity minority and private placement EMEA business as well as the coverage of SWFs, Pension Funds, Family Offices and other long-term capital providers. Prior to Jefferies, Evans Haji-Touma is the founded Moonstone Capital (Moonstone), a London-based independent investment banking and private capital firm focused on Alternative Capital Providers.

Dr. Viljar Palmer

PhD, Vice President of Electro-Polymer Reasearch & Development, XCath, Houston, USA

Viljar Palmer is the ElectroSteer technology inventor and heads up the XCath Houston R&D team. He has close to 20 years of experience in research and development of Smart Materials and Soft Robotics. He was a former Assistant Professor at the University of Texas Health Science Center in Houston and has a Ph.D. in Materials Science and Engineering with over 60 technical publications, including peer-reviewed journal articles, book chapters, and several granted patents.

Dr. Young Hoon Oh

VP Robotics, XCath, Seoul, South Korea

Young Hoon Oh, PhD serves for 19 years in medical and automated machine field. He has been responsible for the development and testing of the device to be used in minimally invasive surgery approach, spinal fusion constructs, dynamic system for human spine, a conceptual pressure and vacuum oven, and the endovascular robots. He was a founding partner of Custom Spine. He holds 5 papers and 20 medical device patents. He is also skilled in the parameter estimation with Unscented Kalman Filter, robotics and dynamics, human spinal motion. He received his master’s and PhD degree from the University of Florida.

Mr. Sham Shiblaq

EVP & Chief Commercial Officer, PROCEPT BioRobotics, San Francisco, USA

Sham Shiblaq is the EVP & Chief Commercial Officer at PROCEPT BioRobotics. PROCEPT is a surgical robotics company focused on delivering a transformative solution in urology via an automated, surgical robotic system to treat BPH. The Company has developed a significant and growing body of clinical evidence, which includes over 150 clinical studies and peer-reviewed publications. PROCEPT generated total revenue of $7.7 million USD in 2020 and is now on pace to generate revenues of $125 million in 2023.

Dr. Abdel Rahman Jaber

Senior Clinical Fellow, Robotic Urologic Oncology, Adventhealth Global Robotics Institute, Orlando, USA

Dr. Jaber received his Undergraduate Degree from Jordan University-Faculty of Medicine. He Joined Hamad Medical Corporation-Qatar in 2013 and completed his Urology residency training in July 2018. He is currently a senior clinical fellow at Adventhealth Global Robotics Institute, Florida. Dr Jaber has been Involved in different Local and International meetings and participated in organizing many conferences.

Dr. Raj Toleti

Chairman and CEO, Andor Health, Windermere, USA

As Chairman & CEO at Andor Health, Raj Toleti guides the company’s vision to change the way care teams connect, communicate and collaborate to reduce clinician burnout, accelerate time-to-treatment and deliver better patient outcomes. He brings more than 20 years of healthcare technology experience to his role. He founded and served as CEO of HealthGrid, a provider of a first-of-its-kind mobile patient engagement platform, which was acquired by Allscripts in 2018. Previously, he founded and served as President of Coordinated Care Solutions at PatientPoint, a leading provider of patient engagement, population health management, and clinical trial enrollment solutions

Dr. Philippe Gallone

Managing Director, Moelis & Company, London, UK

Philippe Gallone is a Managing Director at Moelis & Company where he specializes in advising clients across the healthcare sector. Philippe has over 15 years of investment banking experience, having advised on more than $200 billion worth of M&A transactions in that time. Prior to joining Moelis & Company, Philippe was a Managing Director and Co- Head of EMEA Healthcare Banking at Morgan Stanley. He began his investment banking career at Credit Suisse First Boston. Philippe is a physician by training and received his medical degree from the University of Lausanne. He also holds an M.B.A. from Georgetown University.

Mr. Bruno Stembaum

Managing Director, MedTech Investment Banking Group, Bank of America, New York, USA

Bruno Stembaum is a Managing Director in the MedTech Investment Banking Group at Bank of America. He joined BofA in 2009 in Brazil and relocated to New York in 2015. During the last 15 years, Bruno has worked extensively with both public and private companies on strategic and capital markets transactions. Over the course of his career, he has been involved in almost 100 transactions, including M&A buysides and sellsides worth a combined $65bn+ in deal value and IPOs, equity follow-ons and convertibles that raised more than $30bn of capital.”

Dr. Fred Moll

Pioneer of Robotic Surgery, Palo Alto, USA

Frederic H. Moll, M.D. is widely recognized as the pioneer of surgical robotics, having founded Intuitive Surgical in 1995. In the past 3 decades, Dr Moll has created a number of medical robotics companies, most recently Auris Health, sold to JnJ in 2019. Currently Dr Moll serves as the Chief Development Officer of Johnson & Johnson’s Medical Device Group. Dr. Moll is a director of a number of leading healthcare companies including Shockwave Medical, Procept BioRobotics and Reflexion. He is a general partner of Sonder Capital and a senior advisor to JPMorgan’s newly formed Healthcare Venture Fund. Dr. Moll earned an M.D. from the University of Washington School of Medicine, an M.S. degree from Stanford University, and a B.A. from the University of California at Berkeley